Clinical Trial

FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage

Study acronym: FLASH
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
A multi-centre, prospective, blinded, randomised clinical trial of fludrocortisone compared with placebo in patients presenting with aneurysmal subarachnoid haemorrhage. The study aim is to determine if early administration of enteral fludrocortisone in aneurysmal subarachnoid haemorrhage reduce death and dependency at six months.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-05-07; most recent amendment 2025-12-08.
Status change: Not Yet Recruiting → Recruiting 2025-09-10
Trial Details
NCT Number NCT06409364
Lead Sponsor The George Institute
Conditions Aneurysmal Subarachnoid Hemorrhage
Enrollment 524 participants
Start Date 2025-08-13
Primary Completion 2029-07-31 (estimated)
Study Completion 2030-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-16